BioOutsource To Open New Lab Facility In Massachusetts

Biologics contract testing company BioOutsource announced its plans to open a U.S. lab facility in Massachusetts in 2015.

According to the company, the demand for outsourced testing services has been growing over the past year. Along with the company’s investment in research and development and the recent launch of a BioSimilar Centre of Excellence in Glasgow in February this year, the company decided to establish a new North American Testing Facility in 2015 to keep up with the demand.

Gerry MacKay, BioOutsource CEO, said that the company continues to grow and win greater market share. “Our biggest growth market has without doubt been North America, where we have seen sales triple in the past year… North America has always been an essential strategic element of our global expansion plans, exemplified by our U.S. office and active membership of MassBio. We are already a global company and the time is right to extend our global client footprint with the addition of a new facility in the U.S. The new facility will benefit our existing and new clients, improving logistics and ensuring our technical experts are close by.”

The new lab facility will support BioOutsource’s biosimilar and biosafety service offering. The Massachusetts facility will also focus on serving the company’s North America and Latin American clients.

The company met with Massachusetts governor Deval Patrick and other officials at BIO in San Diego. “We welcome BioOutsource’s expansion in Massachusetts and look forward to their ongoing contributions to our thriving life sciences community,” said Governor Patrick.

Earlier this month, the company also announced its partnership with PsiOxus Therapeutics, in which the company will be supporting the clinical sample analysis of a Phase I/II OCTAVE (Ovarian Cancer) study, to be conducted in Glasgow, UK.